U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.

by Kevin McLaughlin

Women were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.

by Eric Fitzsimmons

Combining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.

by Thomas Celona

Scientists and former administrators gather for session focused on advocating for cancer research in uncertain times.

by Kevin McLaughlin